ID

14836

Beschreibung

Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML; ODM derived from: https://clinicaltrials.gov/show/NCT00069992

Link

https://clinicaltrials.gov/show/NCT00069992

Stichworte

  1. 01.05.16 01.05.16 -
Hochgeladen am

1. Mai 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Chronic Myeloproliferative Disorders NCT00069992

Eligibility Chronic Myeloproliferative Disorders NCT00069992

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
myelodysplastic syndrome with ipss score > 0.(appendix b) or
Beschreibung

ID.1

Datentyp

boolean

Alias
UMLS CUI [1]
C2827405
myeloproliferative disorders
Beschreibung

ID.2

Datentyp

boolean

Alias
UMLS CUI [1]
C0027022
primary myelofibrosis with lile score of 1 or 2 (appendix c)
Beschreibung

ID.3

Datentyp

boolean

Alias
UMLS CUI [1]
C0001815
polycythemia vera or essential thrombocythemia transformed to aml or myelofibrosis and pv "spent phase" or
Beschreibung

ID.4

Datentyp

boolean

Alias
UMLS CUI [1]
C0032463
UMLS CUI [2]
C0040028
UMLS CUI [3]
C0023467
UMLS CUI [4]
C0001815
acute myelogenous leukemia or
Beschreibung

ID.5

Datentyp

boolean

Alias
UMLS CUI [1]
C0023467
chronic myelogenous leukemia
Beschreibung

ID.6

Datentyp

boolean

Alias
UMLS CUI [1]
C0023474
available healthy donor without any contraindications for donation. 5/6 or 6/6 related donor or 5/6 or 6/6 unrelated donor (molecular typing for drb1)
Beschreibung

ID.7

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013018
UMLS CUI [1,2]
C0470187
able to give informed consent
Beschreibung

ID.8

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient is pregnant or lactating or unwilling to use contraceptives.
Beschreibung

ID.9

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
UMLS CUI [1,3]
C0700589
hiv positive patient
Beschreibung

ID.10

Datentyp

boolean

Alias
UMLS CUI [1]
C0019682
uncontrolled intercurrent infection
Beschreibung

ID.11

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
unstable angina and uncompensated congestive heart failure (zubrod of 3 or greater)
Beschreibung

ID.12

Datentyp

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2]
C0018802
severe chronic pulmonary disease requiring oxygen (zubrod of 3 or greater)
Beschreibung

ID.13

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0746102
UMLS CUI [1,2]
C0205082
hemodialysis dependent.
Beschreibung

ID.14

Datentyp

boolean

Alias
UMLS CUI [1]
C0019004
active hepatitis or cirrhosis with total bilirubin, sgot, and sgpt greater than 3 x normal.
Beschreibung

ID.15

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0201899
UMLS CUI [1,2]
C0201836
UMLS CUI [1,3]
C1278039
concurrent solid organ malignancy not in remission, except for stage 0 or a prostate cancer.
Beschreibung

ID.16

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0009488
unstable cerebral vascular disease or recent hemorrhagic stroke (less than 6 months)
Beschreibung

ID.17

Datentyp

boolean

Alias
UMLS CUI [1]
C0007820
active cns disease from hematological disorder.
Beschreibung

ID.18

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007682
UMLS CUI [1,2]
C0018939

Ähnliche Modelle

Eligibility Chronic Myeloproliferative Disorders NCT00069992

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
myelodysplastic syndrome with ipss score > 0.(appendix b) or
boolean
C2827405 (UMLS CUI [1])
ID.2
Item
myeloproliferative disorders
boolean
C0027022 (UMLS CUI [1])
ID.3
Item
primary myelofibrosis with lile score of 1 or 2 (appendix c)
boolean
C0001815 (UMLS CUI [1])
ID.4
Item
polycythemia vera or essential thrombocythemia transformed to aml or myelofibrosis and pv "spent phase" or
boolean
C0032463 (UMLS CUI [1])
C0040028 (UMLS CUI [2])
C0023467 (UMLS CUI [3])
C0001815 (UMLS CUI [4])
ID.5
Item
acute myelogenous leukemia or
boolean
C0023467 (UMLS CUI [1])
ID.6
Item
chronic myelogenous leukemia
boolean
C0023474 (UMLS CUI [1])
ID.7
Item
available healthy donor without any contraindications for donation. 5/6 or 6/6 related donor or 5/6 or 6/6 unrelated donor (molecular typing for drb1)
boolean
C0013018 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
ID.8
Item
able to give informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.9
Item
patient is pregnant or lactating or unwilling to use contraceptives.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
ID.10
Item
hiv positive patient
boolean
C0019682 (UMLS CUI [1])
ID.11
Item
uncontrolled intercurrent infection
boolean
C0009450 (UMLS CUI [1])
ID.12
Item
unstable angina and uncompensated congestive heart failure (zubrod of 3 or greater)
boolean
C0002965 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
ID.13
Item
severe chronic pulmonary disease requiring oxygen (zubrod of 3 or greater)
boolean
C0746102 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
ID.14
Item
hemodialysis dependent.
boolean
C0019004 (UMLS CUI [1])
ID.15
Item
active hepatitis or cirrhosis with total bilirubin, sgot, and sgpt greater than 3 x normal.
boolean
C0201899 (UMLS CUI [1,1])
C0201836 (UMLS CUI [1,2])
C1278039 (UMLS CUI [1,3])
ID.16
Item
concurrent solid organ malignancy not in remission, except for stage 0 or a prostate cancer.
boolean
C0006826 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
ID.17
Item
unstable cerebral vascular disease or recent hemorrhagic stroke (less than 6 months)
boolean
C0007820 (UMLS CUI [1])
ID.18
Item
active cns disease from hematological disorder.
boolean
C0007682 (UMLS CUI [1,1])
C0018939 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video